Lifecode

Foster City, United States Founded: 2012 • Age: 14 yrs Acquired By MedGenome
Molecular tumor profiling panels for solid tumors are developed.
Annual revenue - Latest available
Total funding $20.5M 1 rounds
Employees - Tracked headcount
Investors 3 Known backers
Products 1 Services tracked
Competitors 10 Brand Intelligence

About Lifecode

Lifecode is a company based in Foster City (United States) founded in 2012 was acquired by MedGenome in February 2016. Lifecode has raised $20.5 million across 1 funding round from investors including MedGenome, Sequoia Capital and Mayo Clinic Business Accelerator. Lifecode offers products and services including Pan Cancer Somatic Panel. Lifecode operates in a competitive market with competitors including GRAIL, Color, Strand Life Sciences, Invitae and Genome Medical, among others.

  • Headquarter Foster City, United States
  • Sectors
    Healthcare
  • Phone
    Locked
  • Website
    Locked
  • Social
    Locked
  • Legal Name Lifecode, Inc.
Operational Areas
Healthcare → Biotechnology, Genomics & Life Sciences Research Unlock Sub-Sector Unlock Segment
Healthcare → Biotechnology, Genomics & Life Sciences Research Unlock Sub-Sector Unlock Segment
Healthcare → Healthcare Products & Supplies Unlock Sub-Sector Unlock Segment
Key Metrics
  • Annual Revenue
    Not available
  • Net Profit
    Not available
  • EBITDA
    Not available
  • Total Equity Funding
    $20.5 M (USD)

    in 1 rounds

  • Latest Funding Round
    $20.5 M (USD), Series A

    Feb 18, 2015

  • Investors
    MedGenome

    & 2 more

  • Employee Count
    Not available
  • Acquired by
    MedGenome

    (Feb 24, 2016)

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of Lifecode

Lifecode offers a comprehensive portfolio of products and services, including Pan Cancer Somatic Panel.

Product name locked
Category locked
Primary

Assay for profiling tumors using next-generation sequencing data.

People of Lifecode

Headcount 10-50
Employee Profiles 6
Employee Profiles
People
Burt Demill
Chief Commercial Officer
People
Helen Wang
Founding Member & Head, Curation & Quality
People
Dietrich Stephan
Founding Member & Scientist in Chief
People
Chris Rivest
CEO

Unlock access to complete

Funding Insights of Lifecode

Lifecode has successfully raised a total of $20.5M through 1 strategic funding round. The most recent funding activity was a Series A round of $20.5 million completed in February 2015. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

Investors in Lifecode

Lifecode has secured backing from 3 investors, including venture fund investors. Prominent investors backing the company include MedGenome, Sequoia Capital and Mayo Clinic Business Accelerator.

All
Venture Fund
Investor Description Founded Year Domain Location
Sequoia Capital is engaged in venture capital investments.
Locked Locked Locked
Healthcare startups are accelerated by Mayo Clinic Business Accelerator.
Locked Locked Locked
DNA sequencing, bioinformatics, and multiomics services are provided.
Locked Locked Locked
Premium access

Investor details for Lifecode

Investor domains, locations, round participation, and complete history require an active premium plan.

  • Investor domains
  • Investor locations
  • Funding rounds
  • Participation history

Verified entity values are shown only after access is granted.

Investments & Acquisitions by Lifecode

Investments
Premium access

Investment portfolio details for Lifecode

Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.

  • Portfolio identities
  • Transaction dates
  • Round details
  • Investment values

Verified entity values are shown only after access is granted.

Financial Statements - Lifecode

Premium access

Detailed financials for Lifecode

Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.

  • Historical revenue
  • Profit trends
  • Statement rows
  • Financial ratios

Verified entity values are shown only after access is granted.

Lifecode Comparisons

Lifecode Primary company
Description
Molecular tumor profiling panels for solid tumors are develo...
Location
Foster City, United States
Founded Year
2012
Annual Revenue
Not available
Net Profit
Not available
EBITDA
Not available
Employees
Not available
Premium access

Peer comparison for Lifecode

Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.

  • Named peers
  • Headcount comparison
  • Funding comparison
  • Operating benchmarks

Verified entity values are shown only after access is granted.

+
Add Comparison
Available on Premium

Competitors of Lifecode

Lifecode operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as GRAIL, Color, Strand Life Sciences, Invitae and Genome Medical, among others.

Company Name Domain Founded year HQ Location Description
Locked Locked Locked
Circulating tumor DNA is screened for early cancer detection.
Locked Locked Locked
Cancer care is delivered through a virtual clinic by Color.
Locked Locked Locked
Provider of omics-based solutions for clinical genomics, systems biology, and drug discovery
Locked Locked Locked
Home-based genetic tests for detecting diseases are provided to individuals.
Locked Locked Locked
Genomic testing services are provided clinically and directly to consumers.
Locked Locked Locked
Molecular diagnostics and personalized medicine for cancer are developed.
Premium access

Detailed competitors of Lifecode

Competitor domains, locations, full profiles, and operating metrics require an active premium plan.

  • Domains and locations
  • Full company profiles
  • Operating metrics
  • Competitive positioning

Verified entity values are shown only after access is granted.

Latest news on Lifecode

Premium access

Complete news archive for Lifecode

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Lifecode

Lifecode was founded in 2012 and raised its 1st funding round 3 years after it was founded.

Lifecode is headquartered in Foster City, United States. It is registered at Foster City, California, United States.

Lifecode is a funded company, having raised a total of $20.5M across 1 funding round to date.

Lifecode was founded in 2012 in Foster City, United States, as a CLIA-certified laboratory focused on oncology diagnostics. Panels for complete molecular profiling of solid tumors are developed and offered, with the flagship Pan Cancer Somatic Panel analyzing 52 genes linked to metastatic cancers, rare diseases, and clinical trials. The company was acquired by MedGenome in 2016, continuing operations in the biotechnology sector.

Lifecode's top competitors include GRAIL, Strand Life Sciences and Fulgent Genetics.

Lifecode offers Pan Cancer Somatic Panel.

Lifecode has 3 investors. Key investors include MedGenome, Sequoia Capital, and Mayo Clinic Business Accelerator.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available